Fycompa 12 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F39C4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,034
Award facts
- Contract value 100% obligated
- $1,033.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 6, 2026, by the Defense Logistics Agency to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.), provides FYCOMPA 12 MG tablets in a 30-count package with a ceiling value of $1,033.92 under a firm fixed-price arrangement. The award represents a non-competitive delivery order with an ultimate completion date of January 7, 2026, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This transaction falls under Amerisourcebergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare operations globally.
Amerisourcebergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, with particular emphasis on supporting Department of Defense and veteran healthcare systems. The company maintains a robust portfolio of federal contract awards encompassing specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for FYCOMPA, a neurological treatment medication, exemplifies the company's role in fulfilling routine pharmaceutical supply requirements for military treatment facilities and associated federal healthcare programs under the DLA's expansive pharmaceutical prime vendor contracting structure.
Quick answers
Who was awarded contract SPE2DR26F39C4?
SPE2DR26F39C4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F39C4 worth?
The government has obligated $1,034 on SPE2DR26F39C4.
Is contract SPE2DR26F39C4 an order under another contract?
Yes. SPE2DR26F39C4 is a delivery order under SPE2DR25D1051, an indefinite delivery contract.
Was contract SPE2DR26F39C4 competed?
The extent of competition for SPE2DR26F39C4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award